PBPHvsGDOCETF Comparison
Portfolio Building Block World Pharma and Biotech Index ETF
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. Both ETFs have the same top 1 sector exposures: Healthcare. PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.75% for GDOC. PBPH is up 10.08% year-to-date (YTD) with +$968M in YTD flows. GDOC performs worse with 1.89% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of PBPH and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PBPH vs GDOC performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBPH GDOC | -0.72%-2.76% | +7.13%+7.68% | +10.08%+1.89% | n/a+10.63% | n/a+14.18% | n/an/a |
| Flows | PBPH GDOC | +$35M- | +$139M-$3M | +$968M-$2M | --$3M | --$86M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBPH GDOC | +20.50%+15.32% | n/a+15.27% | n/a+14.96% | n/an/a |
| Max drawdown | PBPH GDOC | -6.59%-6.08% | n/a-15.39% | n/a-22.18% | n/an/a |
| Max drawdown duration | PBPH GDOC | 17d23d | n/a221d | n/a449d | n/an/a |
PBPH | GDOC | |
Last sale 9/11/2026 at 1:30 PM | $27.80 | $36.32 |
| Previous close 09/10/2026 | $27.85 | $36.35 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PBPH | GDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PBPH | GDOC | |
|---|---|---|
| Last price | $27.80 | $36.32 |
| 1D performance | -0.15% | -0.08% |
| AuM | $1.01 B | $19.06 M |
| E/R | 0.13% | 0.75% |
PBPH | GDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Tidal | Goldman Sachs |
| Benchmark | BITA Global Pharma and Biotech Select Index | - |
| N° of holdings | 52 | 38 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 24, 2025 | November 11, 2021 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
